Humana (HUM) Osake Kurssi
Humana Kurssi
Viimeisten 19 vuoden aikana Humanan liikevaihto kasvoi 9,9 % vuodessa ja ylsi 129,66 Mrd. USD:een. Osakekohtainen tulos on kasvanut 6,7 % vuodessa viimeisten 19 vuoden aikana. Humanan nettomarginaali 0,9 % on laskenut verrattuna 3,5 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,82 %. Jakosuhde on noin 36 % tuloksesta. Osinko on kasvanut 11,7 % vuodessa viimeisten 14 vuoden aikana. Humanan 12 kuukauden konsensustavoitehinta on 412,50 USD, noin ali kurssia 4,9 %. 32 analyytikosta 19 suosittaa ostoa — kokonaiskonsensus on Osta.
Humana osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Humana liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Humana -osakkeesta
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analyytikot asettavat tällä hetkellä Humana-osakkeelle keskimääräisen tavoitehinnan 416,78 USD (mediaani: 412,50 USD), mikä merkitsee −3,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 32 analyytikkoarvioon.
32 analyytikkoa arvioi tällä hetkellä Humana-osaketta: 19 suosittaa ostoa, 12 pitoa ja 1 myyntiä. Vuodelle 2026 analyytikot odottavat Humana-yhtiöltä 162,56 Mrd. USD liikevaihtoa ja 9,14 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Humana-osake noteerataan hintaan 387,09 EUR (433,74 USD).
Humana-osake (HUM) on listattuna 7 pörssissä, muun muassa: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
odotettu liikevaihto Humana on 162,56 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Humana on 1,10 Mrd. USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Humana:n hinta-voitto-suhde (P/E) on tällä hetkellä 47,47. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Humana-osakkeen arvostusta.
Humana:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,32. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Humana-osakkeen arvostuskennuslukuna.
Humana:n Eulpool-laatuscore on 5/10.
Humana:n ISIN on US4448591028. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Humana:n WKN on 856584. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Humana:n ticker on HUM. Tämä pörssinoteeraus käytetään Humana-osakkeiden kauppaan pörssissä.
Humana osake
Humana vertaisryhmä
Humana Ticker
Humana FIGI
Kaikki tunnusluvut ja syvällinen analyysi Humana:sta
Meidän osakeanalyysimme Humana-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Humana:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: